Drug Information Analysis Service

Reimer KA Lowe JE Rasmussen MM Jennings RB . The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs. duration of coronary occlusion in dogs. Circulation 1977; 56: 786–94.

Braunwald E Kloner RA . The stunned myocardium: Prolonged postischemic ventricular dysfunction. Circulation 1982; 66: 1146–9.

Manning AS Hearse DJ . Reperfusion-induced arrhythmias: Mechanism and prevention. J Mol Cell Cardiol 1984; 16: 497–518.

Przylklenk K Kloner RA . Superoxide dismutase plus catalase improve contractile function in the canine model of the “stunned myocardium.” Circ Res 1986; 58: 148–56.

Myers ML Bolli R Lekich RF Hartley CJ Roberts R . Enhancement of recovery of myocardial function by oxygen free radical scavengers after reversible regional ischemia. Circulation 1985; 72: 915–21.

Myers ML Bolli R Lekich RF Hartley CJ Roberts R . N-2-mercaptopropionylglycine improves recovery of myocardial function after reversible regional ischemia. J Am Coll Cardiol 1986; 8: 1161–8.

Jeremy RW Allman KC Bautovitch G Harris PJ . Patterns of left ventricular dilation during six months after myocardial infarction. J Am Coll Cardiol 1989; 13: 304–10.

Hutchins GM Bulkley BH . Infarct expansion versus extension: Two different complications of acute myocardial infarction. Am J Cardiol 1978; 41: 1127–32.

Eaton LW Weiss JL Bulkley BH Garrison JB Weisfeldt ML . Regional cardiac dilatation after acute myocardial infarction: Recognition by two-dimensional echocardiography. N Engl J Med 1979; 300: 57–62.

McKay RG Pfeffer MA Pasternak RC Markis JE Come PC Nakao S . Left ventricular remodeling after myocardial infarction: A corollary to infarct expansion. Circulation 1986; 74: 693–702.

Gaudron PJ Eilles C Ertl G . Subacute adaptation to loss of contractile myocardium by left ventricular dilatation (remodeling) in patients with myocardial infarction (abstract). Circulation 1987; 76 (suppl IV):402.

Pfeffer MA Pfeffer JM . Ventricular enlargement and reduced survival after myocardial infarction. Circulation 1987; 75 (suppl IV):93–7.

Kannel WB Sorlie P McNamara PM . Prognosis after initial myocardial infarction: The Framingham Study. Am J Cardiol 1979; 44: 53–9.

White HD Norris RM Brown MA Brandt PWT Whitlock RMC Wild CJ . Left ventricular end systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987; 76: 44–51.

Westlin W Mullane K . Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals? Circulation 1988; 77 (suppl I): 30–9.

Pfeffer MA Lamas GA Vaughan DE Parisi AF Braunwald E . Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988; 319: 80–6.

Rubin SA . Effect of captopril on ventricular dilatation after anterior myocardial infarction (letter). N Engl J Med 1988; 319: 1736.

Fishbein MC Lei LQ Rubin SA . Long-term propranolol administration alters myocyte and ventricular geometry in rat hearts with and without infarction. Circulation 1988; 78: 369–75.

Black I . Effect of captopril on ventricular dilatation after anterior myocardial infarction (letter). N Engl J Med 1988; 319: 1736.

Pfeffer MA Lamas G Braunwald E . Effect of captopril on ventricular dilatation after anterior myocardial infarction (letter). N Engl J Med 1988; 319: 1736.

Sharpe N Murphy J Smith H Hannan S . Preventive treatment of asymptomatic left ventricular dysfunction following myocardial infarction. Eur Heart J 1990; 11 (suppl B):147–56.

Sharpe N Smith H Murphy J Greaves S Hart H Gamble G . Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting enzyme inhibition. Lancet 1991; 337: 872–6.

Nabel EG Topol EJ Galeana A Ellis SG Bates ER Werns SW . A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction. J Am Coll Cardiol 1991; 17: 467–73.

Pfeffer MA Moye LA Braunwald E Basta L Brown EJ Cuddy TE . Selection bias in the use of thrombolytic therapy in acute myocardial infarction. JAMA 1991; 266: 528–32.

Murray BE . The life and times of the Enterococcus Clin Microbiol Rev 1990; 3: 46–65.

Gray JW Stewart D Pedler SJ . Species identification and antibiotic susceptibility testing of enterococci isolated from hospitalized patients. Antimicrob Agents Chemother 1991; 35: 1943–5.

Leclercq R Derlot E Duval J Courvalin P . Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium N Engl J Med 1988; 319: 157–61.

Sahm DF Kissinger J Gilmore MS Murray PR Mulder R Solliday J . In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis Antimicrob Agents Chemother 1989; 33: 1588–91.

Wolfson JS Hooper DC . Fluoroquinolone antimicrobial agents. Clin Microbiol Rev 1989; 2: 378–424.

Kim MJ Weiser M Gottschall S Randall EL . Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents. J Clin Microbiol 1987; 25: 787–90.

Perez JL Riera L Valls F Berrocal CI Berrocal L . A comparison of the in-vitro activity of seventeen antibiotics against Streptococcus faecalis J Antimicrob Chemother 1987; 20: 357–62.

Vance-Bryan K Guay DRP Rotschafer JC . Clinical pharmacokinetics of ciprofloxacin. Clin Pharmacokinet 1990; 19: 434–61.

Sahm DF Koburov GT . In vitro activity of quinolones against enterococci resistant to penicillin—aminoglycoside synergy. Antimicrob Agents Chemother 1989; 33: 71–7.

Fernandez-Guerrero M Rouse MS Henry NK Geraci JE Wilson WR . In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis. Antimicrob Agents Chemother 1987; 31: 430–3.

Smith SM Eng RHK . Interaction of ciprofloxacin with ampicillin and vancomycin for Streptococcus faecalis Diagn Microbiol Infect Dis 1988; 9: 239–43.

Sanders WE Jr . Efficacy, safety, and potential economic benefits of oral ciprofloxacin in the treatment of infections. Rev Infect Dis 1988; 10: 528–43.

Chrysanthopoulos CJ Starakis JC Skoutelis AT Bassaris HP . Brief report: Sequential intravenous/oral therapy with ciprofloxacin in severe infection. Am J Med 1989; 87 (suppl 5A):S225–7.

Eron LJ Harvey L Hixon DL Poretz DM . Ciprofloxacin therapy of infections caused by Pseudomonas aeruginosa and other resistant bacteria. Antimicrob Agents Chemother 1985; 27: 308–10.

Peacock JE Jr Pegram PS Weber SF Leone PA . Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections. Am J Med 1989; 87 (suppl 5A):S185–90.

Powers T Bingham DH . Clinical and economic effect of ciprofloxacin as an alternative to injectable antimicrobial therapy. Am J Hosp Pharm 1990; 47: 1781–4.

Rapp RP Billeter M Hatton J Young AB Tibbs PA Dempsey RJ . Intravenous ciprofloxacin versus ceftazidime for treatment of nosocomial pneumonia and urinary tract infection. Clin Pharm 1991; 10: 49–55.

Eron LJ . Therapy of skin and skin structure infections with ciprofloxacin: An overview. Am J Med 1987; 82 (suppl 4A):S224–6.

Gentry LO Rodriguez-Gomez G . Ofloxacin versus parenteral therapy for chronic osteomyelitis. Antimicrob Agents Chemother 1991; 35: 538–41.

Scully BE Neu HC . Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosa. J Antimicrob Chemother 1986; 18 (suppl D): 179–85.

Swedish Study Group. Therapy of acute and chronic gram-negative osteomyelitis with ciprofloxacin. J Antimicrob Chemother 1988; 22: 221–8.

Zervos MJ Bacon AE Patterson JE Schaberg DR Kauffman CA . Enterococcal superinfection in patients treated with ciprofloxacin. J Antimicrob Chemother 1988; 21: 113–5.

Khan FA Basir R . Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections. Chest 1989; 96: 528–37.

Brown JR Beebe GW Kurtzke JF Loewenson RB Silberberg DH Tourtellote WW . The design of clinical studies to assess therapeutic efficacy in multiple sclerosis. Neurology 1979; 29: 3–23.

Waxman SG . Current concepts in neurology: Membranes, myelin and the pathophysiology of multiple sclerosis. N Engl J Med 1982; 306: 1529–32.

Kurtzke JF . Epidemiologic contributions to multiple sclerosis: An overview. Neurology (NY) 1980; 30: 61–79.

McFarlin DE McFarland HF . Multiple sclerosis: Part I. N Engl J Med 1982; 307: 1183–8.

McAlpine D Lumsden CE Acheson ED . Multiple sclerosis: a reappraisal. Edinburgh: Churchill Livingstone, 1972.

McFarlin DE McFarland HF . Multiple sclerosis: Part II. N Engl J Med 1982; 307: 1246–51.

Quick DC Waxman SG . Specific staining of the axon membrane at nodes of Ranvier with ferric ion and ferrocyanide. J Neurol Sci 1977; 31: 1–11.

Waxman SG Quick DC . Cytochemical differentiation of the axon membrane and A and C fibers. J Neurol Neurosurg Psychiatry 1977; 40: 379–85.

Tasaki I . Conduction of the nerve impulse. In: Field J ed. Neurophysiology: Handbook of physiology, section 1. Washington, DC: American Physiological Society, 1959: 75–121.

Chiu SY Ritchie JM Robart RB Stagg D . A quantitative description of membrane currents in rabbit myelinated nerve. J Physiol (Lond) 1979; 292: 149–66.

Brismar T . Potential clamp analysis of membrane currents in rat myelinated nerve fibers. J Physiol (Lond) 1980; 298: 171–84.

Ritchie JM Shiu SY . Distribution of sodium and potassium channels in mammalian myelinated nerve. In: Waxman SG Ritchie JM eds. Demyelinating disease: Basic and clinical electrophysiology. New York: Raven Press, 1981: 329–42.

Kaji R Sumner AJ . Effect of digitalis on central demyelinated conduction block in vivo. Ann Neurol 1989; 25: 1364–8.

Kaji R Sumner AJ . Ouabain reverses conduction disturbances in single demyelinated nerve fibers. Neurology 1989; 39: 1364–8.

Kaji R Happel L Sumner AJ . Effect of digitalis on clinical symptoms and conduction variable in patients with multiple sclerosis. Ann Neurol 1990; 28: 582–4.

Garan H Smith TW Powell WJ Jr . The central nervous system as a site of action for the coronary vasoconstrictor effect of digoxin. J Clin Invest 1974; 54: I365–72.